General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study
about
Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitisThe 3020insC Allele of NOD2 Predisposes to Cancers of Multiple OrgansInflammatory bowel disease. 3: importance of partnership in care.Inflammatory bowel disease cause-specific mortality: a primer for cliniciansReview article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease.Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001Clinical epidemiology--how important now?Risk of haematopoietic cancer in patients with inflammatory bowel disease.Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort.Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis.Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004.Acute myeloid leukemia developing in patients with autoimmune diseases.Methodology for high-quality studies on course and prognosis of inflammatory bowel disease.Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.Does smoking reduce infliximab's effectiveness against Crohn's disease?Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts.A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.Mortality from inflammatory bowel diseases.Melatonin's protective effect against UV radiation: a systematic review of clinical and experimental studies.European evidence based consensus for endoscopy in inflammatory bowel disease.Smoking and early infliximab response in Crohn’s disease: a meta-analysis.Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease.Inflammatory bowel disease of the elderly: a wake-up call.Clinical course and prognosis in ulcerative colitis: results from population-based and observational studiesRisky business? Crohn's disease-related mortality.The risk of colorectal cancer is related to frequent hospitalization of IBD in an Asian population: results from a nationwide study.Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland.Cancer in inflammatory bowel disease 15years after diagnosis in a population-based European Collaborative follow-up study
P2860
Q27011853-98FE75CF-1219-4587-A591-C19243B46BD9Q33722537-7C811174-10CC-4A42-A8F7-11AF23E870DEQ33859030-27C60F13-1BC8-4A8B-9A84-ABF85F739558Q34570452-DD53ABD6-CA59-4C20-9829-4C3C68E5D368Q34609407-6A443C14-B7B9-4F78-A870-E054C9EA7E99Q35243557-3A06B5E3-68B5-433B-B351-4B3D09EFCF9BQ35359125-00A6552F-E7D1-498F-B9B5-E5EA3923CE03Q35596817-ABFA30E3-29CF-4F54-A700-9F86FA0BD00DQ35597321-7DEC90DC-8828-45E2-A475-CC24475AABB0Q35597348-D804930B-FDC3-4AE0-97DC-6580C63C2647Q35760428-78A2BC0E-C157-4ACD-A0A9-A15B8A0A10D1Q35761403-C85D83F3-6EA6-4150-A43C-6750F4E84B30Q35768946-7D44C2CF-2D32-4187-B765-D9276E050064Q36006358-E6225848-3F5A-4C7C-8A1D-82538F75EC15Q36144464-F936CECF-3C36-49A6-A315-EC9AE8BB9780Q37126766-6E1E4213-3E4D-44F6-8FB6-557B4F594BD0Q37223014-0DA8C0A7-10E7-4387-9497-CC837DA5F57CQ37781314-13467B97-D17F-4977-A4DF-B64A424D3A23Q37814549-B318CB3A-88C1-40E5-AB38-F6848D17C907Q37978588-189F1398-0FB8-42E7-B772-145918A2992AQ38155904-585EDBCA-2F16-456E-B893-C4FB6C6EBF6AQ38159096-09B964EE-316A-4771-8EC9-44DA5BF36765Q38291955-97C7CE48-8191-46D4-8E88-FABF8A5A312AQ41842564-EB31A91C-126C-4985-9C5F-DF046B61807CQ42019607-FB724BF6-100C-41DF-9521-E787577465F3Q42360841-E8A90830-F899-4A78-A41D-0904305FE872Q43637280-DA035E03-8DC8-400B-9D7D-640D15589000Q48182692-806CC800-0A56-474F-B477-89E32EBE3458Q50766020-C275FDB5-47B4-4A1C-A9FB-856CB74B6773Q57265352-7FDBD900-6A05-4BE4-8502-BB7073EDCAC2
P2860
General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
General and cancer specific mo ...... el disease: the Florence Study
@ast
General and cancer specific mo ...... el disease: the Florence Study
@en
type
label
General and cancer specific mo ...... el disease: the Florence Study
@ast
General and cancer specific mo ...... el disease: the Florence Study
@en
prefLabel
General and cancer specific mo ...... el disease: the Florence Study
@ast
General and cancer specific mo ...... el disease: the Florence Study
@en
P2093
P2860
P356
P1433
P1476
General and cancer specific mo ...... el disease: the Florence Study
@en
P2093
D'Albasio G
Tarantino O
Trallori G
P2860
P304
P356
10.1136/GUT.42.2.175
P407
P577
1998-02-01T00:00:00Z